Noninvasive Relative Quantification of [11C]ABP688 PET Imaging in Mice Versus an Input Function Measured Over an Arteriovenous Shunt

Impairment of the metabotropic glutamate receptor 5 (mGluR5) has been implicated with various neurologic disorders. Although mGluR5 density can be quantified with the PET radiotracer [ C]ABP688, the methods for reproducible quantification of [ C]ABP688 PET imaging in mice have not been thoroughly in...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in neurology Vol. 9; p. 516
Main Authors Verhaeghe, Jeroen, Bertoglio, Daniele, Kosten, Lauren, Thomae, David, Verhoye, Marleen, Van Der Linden, Annemie, Wyffels, Leonie, Stroobants, Sigrid, Wityak, John, Dominguez, Celia, Mrzljak, Ladislav, Staelens, Steven
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 29.06.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Impairment of the metabotropic glutamate receptor 5 (mGluR5) has been implicated with various neurologic disorders. Although mGluR5 density can be quantified with the PET radiotracer [ C]ABP688, the methods for reproducible quantification of [ C]ABP688 PET imaging in mice have not been thoroughly investigated yet. Thus, this study aimed to assess and validate cerebellum as reference region for simplified reference tissue model (SRTM), investigate the feasibility of a noninvasive cardiac image-derived input function (IDIF) for relative quantification, to validate the use of a PET template instead of an MRI template for spatial normalization, and to determine the reproducibility and within-subject variability of [ C]ABP688 PET imaging in mice. Blocking with the mGluR5 antagonist MPEP resulted in a reduction of [ C]ABP688 binding of 41% in striatum ( < 0.0001), while no significant effect could be found in cerebellum (-4.8%, > 0.99) indicating cerebellum as suitable reference region for mice. DVR-1 calculated using a noninvasive IDIF and an arteriovenous input function correlated significantly when considering the cerebellum as the reference region (striatum: DVR-1, = 0.978, < 0.0001). Additionally, strong correlations between binding potential calculated from SRTM (BP ) with DVR-1 based on IDIF (striatum: = 0.980, < 0.0001) and AV shunt (striatum: = 0.987, < 0.0001). BP displayed higher discrimination power than V values in determining differences between wild-types and heterozygous Q175 mice, an animal model of Huntington's disease. Furthermore, we showed high agreement between PET- and MRI-based spatial normalization approaches (striatum: = 0.989, < 0.0001). Finally, both spatial normalization approaches did not reveal any significant bias between test-retest scans, with a relative difference below 5%. This study indicates that noninvasive quantification of [ C]ABP688 PET imaging is reproducible and cerebellum can be used as reference region in mice.
Bibliography:Reviewed by: Christine DeLorenzo, Stony Brook University, United States; Adriaan Anthonius Lammertsma, VU University Medical Center, Netherlands
This article was submitted to Applied Neuroimaging, a section of the journal Frontiers in Neurology
Edited by: Freimut Dankwart Juengling, St. Claraspital Basel, Switzerland
ISSN:1664-2295
1664-2295
DOI:10.3389/fneur.2018.00516